Ensysce Biosciences Inc (NAS:ENSC)
$ 0.45 -0.0253 (-5.32%) Market Cap: 3.41 Mil Enterprise Value: 447,000.00 PE Ratio: 0 PB Ratio: 0.88 GF Score: 24/100

Ensysce Biosciences Inc Extraordinary Shareholders Meeting Transcript

Mar 23, 2023 / 04:00PM GMT
Release Date Price: $5.76 (-4.35%)
Operator

Greetings. Welcome to the special meeting of stockholders of Ensysce Biosciences, Inc. (Operator Instructions) Please note that this conference is being recorded. I would now like to turn the conference over to your host, Dr. Lynn Kirkpatrick, Chief Executive Officer of Ensysce Biosciences. Please go ahead.

Lynn Kirkpatrick
Ensysce Biosciences, Inc. - CEO

Good morning, ladies and gentlemen. And welcome to the special meeting of stockholders of Ensysce Biosciences, Inc. being held virtually. I am Dr. Lynn Kirkpatrick, President and Chief Executive Officer, and I will act as Chair of the meeting.

I would like to introduce Dave Humphrey, our Chief Financial Officer. We are also pleased to have with us Eric Kline of Troutman Pepper, our outside legal counsel.

As we begin, I would like to remind our stockholders that the meeting may include forward-looking statements which are any predictions, projections, or other statements about future events based on current expectations and assumptions. Actual results may differ materially from those forward

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot